NXT Biomedical

NXT Biomedical is an early-stage medical device incubator dedicated to developing and commercializing innovative medical technologies that address significant clinical needs. The company focuses on improving patient outcomes and reducing healthcare costs by bringing clinically relevant medical devices to market. Over the next five years, NXT Biomedical plans to invest $25 million to create five to eight startup companies from its incubator platform. Led by Stanton J. Rowe, a seasoned executive in the medical device industry, NXT Biomedical identifies and develops advanced biomedical technologies. The company partners with Deerfield Management to fund its initiatives, concentrating on diseases with substantial unmet medical needs. Its portfolio includes technologies like a novel right-sided cardiovascular shunt and other advanced medical devices aimed at enhancing clinical outcomes. NXT Biomedical primarily serves healthcare providers and systems, offering innovative treatment options that improve patient care and reduce costs.

• Employees2
• Founded2018
• Total Funding$10000000